Mushroom Medicine.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      The article reports on the use of psilocybin for treatment-resistant depression. It mentions the research of George Goldsmith and Ekaterina Malievskaia of Compass Pathways Ltd. that has lead to clinical trials of a synthetic form of psilocybin, and the growing acceptance of the U.S. Federal Drug Administration towards therapeutic use of psychedelic drugs.